A pilot study of docetaxel-carboplatin versus paclitaxel-carboplatin in Japanese patients with epithelial ovarian cancer

被引：0
|
作者：
Taisuke Mori
Kenichi Hosokawa
Yoshiyuki Kinoshita
Ai Watanabe
Takeshi Yamaguchi
Haruo Kuroboshi
Yoshiko Kato
Jinsuke Yasuda
Hiroyuki Fujita
Yoshinori Nakata
Hideo Honjo
机构：
[1] Kyoto Prefectural University of Medicine,Department of Obstetrics and Gynecology
来源：
International Journal of Clinical Oncology | 2007年 / 12卷
关键词：
Ovarian cancer; Docetaxel; Paclitaxel; Toxicity; Quality of life;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：205 / 211
页数：6
相关论文
共 50 条
  • [21] Paclitaxel-cisplatin vs. paclitaxel-Carboplatin in previously untreated ovarian cancer
    Neijt, JP
    Engelholm, SA
    Tuxen, M
    Sorensen, PG
    Hansen, M
    Sessa, C
    de Swart, CAM
    Hirsch, FR
    Witteveen, PO
    Lund, B
    Hansen, SW
    Palle, B
    Roer, O
    van Houwelingen, HC
    ANNALS OF ONCOLOGY, 1998, 9 : 65 - 65
  • [22] Paclitaxel/carboplatin versus topotecan/paclitaxel/carboplatin in patients with FIGO suboptimally resected stage III-IV epithelial ovarian cancer a multicenter, randomized study
    Bolis, Giorgio
    Scarfone, Giovanna
    Raspagliesi, Francesco
    Mangili, Giorgia
    Danese, Saverio
    Scollo, Paolo
    Lo Russo, Domenica
    Villa, Antonella
    Aimone, Paola Daniela
    Scambia, Giovanni
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (16) : 2905 - 2912
  • [23] Carboplatin-paclitaxel- and carboplatin-docetaxel-induced cytotoxic effect in epithelial ovarian carcinoma in vitro
    Engblom, P
    Rantanen, V
    Kulmala, J
    Grènman, S
    CANCER, 1999, 86 (10) : 2066 - 2073
  • [24] Paclitaxel/carboplatin versus single-agent carboplatin in patients with epithelial ovarian cancer and correlation to serum marker VEGF.
    Malek, R. A.
    Amin, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [25] Is macrocytosis a potential biomarker of the efficacy of dose-dense paclitaxel-carboplatin combination therapy in patients with epithelial ovarian cancer?
    Jelavic, Tihana Boraska
    Boban, Toni
    Brcic, Luka
    Vrdoljak, Eduard
    ANTI-CANCER DRUGS, 2017, 28 (08) : 922 - 927
  • [26] Five cases of skin desquamation due to bevacizumab combined with docetaxel-carboplatin in ovarian cancer
    Megumi Tokunaga
    Shuichi Nawata
    Takayuki Komoto
    Rei Mathuura
    Daisuke Ichikura
    Toru Watanabe
    Tadanori Sasaki
    International Cancer Conference Journal, 2023, 12 : 49 - 52
  • [27] Clinical trial and pharmacokinetic study of combination paclitaxel and carboplatin in patients with epithelial ovarian cancer
    Ritsu Yamamoto
    Masanori Kaneuchi
    Masashi Nishiya
    Yukiharu Todo
    Mahito Takeda
    Kazuhira Okamoto
    Hiroaki Negishi
    Noriaki Sakuragi
    Seiichiro Fujimoto
    Takeshi Hirano
    Cancer Chemotherapy and Pharmacology, 2002, 50 : 137 - 142
  • [28] Clinical trial and pharmacokinetic study of combination paclitaxel and carboplatin in patients with epithelial ovarian cancer
    Yamamoto, R
    Kaneuchi, M
    Nishiya, M
    Todo, Y
    Takeda, M
    Okamoto, K
    Negishi, H
    Sakuragi, N
    Fujimoto, S
    Hirano, T
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2002, 50 (02) : 137 - 142
  • [29] A clinical and pharmacokinetic study of the combination of carboplatin and paclitaxel for epithelial ovarian cancer
    N Siddiqui
    AV Boddy
    HD Thomas
    NP Bailey
    L Robson
    MJ Lind
    AH Calvert
    British Journal of Cancer, 1997, 75 : 287 - 294
  • [30] A clinical and pharmacokinetic study of the combination of carboplatin and paclitaxel for epithelial ovarian cancer
    Siddiqui, N
    Boddy, AV
    Thomas, HD
    Bailey, NP
    Robson, L
    Lind, MJ
    Calvert, AH
    BRITISH JOURNAL OF CANCER, 1997, 75 (02) : 287 - 294
12345